Re: Why up today
Breakaway gap up on volume of 16,854,686 shares with no news except the JMP upgrade.
I think it is due to Galidesivir Brazilian clinical trial pending news that is due "this summer". Or maybe there is finally Gali COVID-19 animal study news about to be released. Then again, might be a Factor D "pipeline in a molecule" update. Another consideration is the Japanese could be granting approval for Berotralstat sooner than expected.
Take your pick on which catalyst comes first. It is going to be a very profitable Summer 2020 for BCRX longs.